High-Dose Vitamin E Has Anticoagulant Properties. Warfarin Users Need to Monitor
Supplemental vitamin E above 400 IU per day can inhibit vitamin K-dependent clotting factors and potentiate warfarin. Here's what studies found about the mechanism and risk.
Vitamin E is a fat-soluble antioxidant found in nuts, seeds, and vegetable oils. As a supplement, it is commonly taken for heart health, skin, and general antioxidant purposes. At high doses, it has pharmacological activity on blood clotting that becomes clinically relevant for people on anticoagulant therapy.
How high-dose vitamin E affects coagulation
Vitamin E, specifically alpha-tocopherol, inhibits platelet aggregation and has effects on several coagulation factors. At supplemental doses above 400 IU per day, it can antagonise vitamin K-dependent clotting factors by interfering with vitamin K metabolism.
Vitamin K is essential for the activation of several proteins involved in the clotting cascade, including factors II (prothrombin), VII, IX, and X, as well as proteins C and S. Warfarin works by blocking vitamin K recycling, reducing the activity of these same factors. When vitamin E also impairs vitamin K function through a different mechanism, the combined effect is a further reduction in clotting factor activity.
Clinical evidence
A double-blind crossover study found that vitamin E supplementation significantly increased INR in patients on stable warfarin therapy. The magnitude of the effect was dose-dependent, with greater effects at higher vitamin E doses.
Case reports have documented bleeding events in people on warfarin who added high-dose vitamin E. A systematic review of vitamin E’s effects on coagulation parameters noted consistent findings across studies: doses above 400 IU per day reliably extended clotting time in anticoagulated patients.
The distinction between dietary and supplemental intake
Vitamin E from food sources rarely reaches doses high enough to produce this effect. A varied diet typically provides 7–15 IU of vitamin E daily. The interaction is specific to supplemental use, which commonly involves capsules delivering 400–1,000 IU, sometimes marketed as antioxidant support or for cardiovascular health.
Many supplement users take vitamin E in this range without being aware of its anticoagulant properties. Unlike fish oil, which is increasingly recognised as having blood-thinning effects, vitamin E’s anticoagulant activity is less widely known outside clinical pharmacology.
For people on warfarin
People on warfarin who want to take vitamin E should inform their anticoagulation clinic. INR monitoring — already routine for warfarin users — would detect any shift in clotting parameters. The warfarin dose can be adjusted accordingly if needed, rather than simply avoiding vitamin E altogether.
Reference
- Kim JM, White RH. "Effect of vitamin E on the anticoagulant response to warfarin." American Journal of Cardiology, 1996. PubMed 15559946
